Dashboard
Manage Tickers

ARTL ARTELO BIOSCIENCES, INC.


$ 1.70 $ -0.04 (-2.34 %)    

Friday, 21-Nov-2025 15:49:11 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 590.52 $ 4.40 (0.75 %)
DIA $ 462.60 $ 5.05 (1.1 %)
SPY $ 658.99 $ 6.50 (1 %)
TLT $ 89.49 nm (nm)
GLD $ 373.48 $ -0.58 (-0.15 %)
$ na
$ 1.66
$ 1.70 x 1
$ 1.74 x 21
$ 1.63 - $ 1.75
$ 1.55 - $ 28.60
26,791
na
3.37M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

maxim-group-downgrades-artelo-biosciences-to-hold
Maxim Group Downgrades Artelo Biosciences ...
11/19/2025 15:48:46

Maxim Group analyst Jason McCarthy downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.

artelo-biosciences-q3-eps-397-misses-082-estimate
Artelo Biosciences Q3 EPS $(3.97) Misses $...
11/12/2025 13:28:42

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(3.97) per share which missed the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 17:06:03

artelo-biosciences-announces-publication-of-peer-reviewed-article-the-emerging-role-of-fatty-acid-binding-protein-3-fabp3-in-cancers-in-drug-discovery-today
Artelo Biosciences Announces Publication O...
11/04/2025 13:34:22

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways ...

artelo-biosciences-appoints-mark-spring-cfo-effective-nov-1
Artelo Biosciences Appoints Mark Spring CF...
10/27/2025 12:01:35

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways ...

artelo-biosciences-reports-phase-1-and-2-data-for-art2612-and-art2713-highlighting-safety-and-significant-weight-gain-in-cancer-anorexia-trial
Artelo Biosciences Reports Phase 1 And 2 D...
10/15/2025 13:18:39

ART26.12 Phase 1 Data Demonstrated No Safety Concerns, Predictable Linear Plasma Exposure, and Options for Dosing in Either Fed...

artelo-biosciences-prices-20m-public-offering
Artelo Biosciences Prices $2.0M Public Off...
09/30/2025 14:11:59

SOLANA BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutic...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 12:09:34

why-wolfspeed-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket
Why Wolfspeed Shares Are Trading Higher By...
09/30/2025 09:37:13

reported-earlier-artelo-biosciences-commences-underwritten-public-offering-of-common-stock-and-pre-funded-warrants
Reported Earlier, Artelo Biosciences Comme...
09/30/2025 06:34:00

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

artelo-biosciences-announces-publication-of-new-preclinical-data-on-art1211-proprietary-cannabidioltetramethylpyrazine-cocrystal
Artelo Biosciences Announces Publication O...
09/10/2025 12:36:52

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways...

this-science-applications-international-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-monday
This Science Applications International An...
09/08/2025 13:35:13

d-boral-capital-downgrades-artelo-biosciences-to-hold
D. Boral Capital Downgrades Artelo Bioscie...
09/08/2025 11:21:26

D. Boral Capital analyst Jason Kolbert downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.

nasdaq-gains-over-100-points-science-applications-shares-fall-after-q2-results
Nasdaq Gains Over 100 Points; Science Appl...
09/04/2025 19:06:34

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

dow-surges-200-points-us-initial-jobless-claims-rise
Dow Surges 200 Points; US Initial Jobless ...
09/04/2025 16:37:17

artelo-biosciences-prices-640924-share-offering-at-440share-and-pre-funded-warrants-at-4399-proceeds-3m
Artelo Biosciences Prices 640,924 Share Of...
09/04/2025 12:40:23

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/03/2025 21:06:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION